The following seven proposed Local Coverage Determinations (LCDs) have been published for review and comments for contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Medicare Coverage Database Number	LCD Title
DL37822, DA57773	MolDX: Breast Cancer Index (BCI) Gene Expression Test
DL37295, DA57607	MolDX: EndoPredict Breast Cancer Gene Expression Test
DL38629, DA58168	MolDX: Liquid Biopsies for Solid Organ Transplantation
DL38643, DA58183	MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells
DL38647, DA58181	MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
DL38625, DA58162	Lab: Urine Drug Testing
DL34228, DA56572	Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)

 

Comment Period: May 28, 2020 - July 12, 2020

View the CMS MCD to access Proposed LCDs not released to final LCDs.

Providers may address details for comment submission. When sending comments, reference the specific policy to which they are related. See the Proposed LCDs webpage for email and mail specifics.